title: Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds.
abstract: We report the clinical and neuropathological characteristics occurring in 180 demented individuals from 24 kindreds with familial Alzheimer's disease (FAD). Each family had at least two affected generations, and at least one autopsy or brain biopsy was compatible with the diagnosis of AD. Forty-nine neuropathological specimens or reports were reviewed. Mean age of onset for the total group was 54.7 years +/- 11.5, with a large range of 30 to 84 years. Mean age at death was 63.5 years +/- 12.2, with a range of 46 to 85. Mean duration of disease was 8.8 years +/- 4.4, with a range of 1 to 23 years. Six findings suggested phenotypic heterogeneity in FAD. (1) Five families represented an early age of onset group with mean onset at 42 years (range 30 to 51 years) and mean disease duration of 6.7 years. (2) Eight families represented a late onset group with mean onset at 68 years (range 59 to 78 years) and a mean duration of 8.5 years. (3) Seven families were of Volga German ancestry, all originating from the same two villages in Russia. Mean age of onset was 55.9 years (range 40 to 72 years), with a mean disease duration of 10 years. This group probably represents the genetic founder effect of an autosomal dominant gene for AD. (4) One family had the unusual characteristics of neurofibrillary tangles and granulovacuolar change but no amyloid plaques, a mean disease duration of more than 11 years, and a "schizophrenia-like" onset. (5) One family with late onset also had clinical and pathological evidence for anterior horn cell disease. (6) Two autopsies in 1 family both showed remarkable rarefaction of myelin and expansion of perivascular spaces in centrum semiovale (état criblé), with marked leptomeningeal and cortical amyloid angiopathy, distinct from the other FAD brains. It remains to be determined whether the clinical and pathological differences between these families represent genetic heterogeneity at the biochemical or molecular level.
authors.affiliation: University of Washington Medical School, Seattle.
authors.forename: T D
authors.initials: TD
authors.lastname: Bird
authors.forename: S M
authors.initials: SM
authors.lastname: Sumi
authors.forename: E J
authors.initials: EJ
authors.lastname: Nemens
authors.forename: D
authors.initials: D
authors.lastname: Nochlin
authors.forename: G
authors.initials: G
authors.lastname: Schellenberg
authors.forename: T H
authors.initials: TH
authors.lastname: Lampe
authors.forename: A
authors.initials: A
authors.lastname: Sadovnick
authors.forename: H
authors.initials: H
authors.lastname: Chui
authors.forename: G W
authors.initials: GW
authors.lastname: Miner
authors.forename: J
authors.initials: J
authors.lastname: Tinklenberg
mesh_terms: D000328:Adult; D000368:Aged; D000544:Alzheimer Disease / Q000235:genetics* / Q000473:pathology; D001921:Brain / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009454:Neurofibrils / Q000473:pathology; D010375:Pedigree; D010641:Phenotype